Abstract: A method for reporting uplink control information (UCI) on a user equipment (UE) is described. The UCI is coded using a first block coder and a second block coder to obtain an output bit sequence. The output bit sequence is scrambled to obtain a scrambled signal. A block of complex-valued modulation symbols is generated from the scrambled signal for physical uplink control channel (PUCCH) Format 3. The first block coder and the second block coder use a Reed-Muller code.

Abstract: A terminal that communicates with a base station monitors a physical downlink control channel allocated in a physical downlink control channel region and an enhanced physical downlink control channel allocated in a physical downlink shared channel region different from the physical downlink control channel region. If the enhanced physical downlink control channel is detected, the terminal reports response information via a physical uplink control channel resource corresponding to the resource in which the enhanced physical downlink control channel was detected.

Abstract: This display device is provided with: a circuit substrate having a display region and a non-display region; pixel-driving TFTs for driving pixels, formed in the display region and having source electrodes and drain electrodes being spaced apart from each other on an insulating film and a first active layer formed from an oxide semiconductor, provided on the opposite side from the insulating film so as to cover a separation section between a source electrode and a drain electrode and part of the source electrode and part of the drain electrode adjacent to the separation section; and a driver circuit TFT for driving the pixel-driving TFTs, formed in the non-display region and having a second active layer formed from a non-oxide semiconductor.

Abstract: A touch panel system (611) includes a touch invalidating section (609) which, in a case where a specific point of the sensor panel (601) is continuously touched for a predetermined period of time, invalidates an instruction given, in accordance with the touch, to a host computer (610). Furthermore, the touch invalidating section (609) invalidates an instruction corresponding to a next touch on the point.

Abstract: In an operation unit, a display panel displays a two-sided copy setting screen image including a still image display area on which a plurality of software keys (two-sided copy setting keys) corresponding to respective ones of a plurality of processes (one-sided/one-sided copy process, one-sided/two-sided copy process, two-sided/two-sided copy process and two-sided/one-sided copy process), for selecting any of the plurality of processes, are displayed. A touch-panel receives an input operation to the plurality of software keys. In response to the touch-panel receiving the input operation, a CPU displays, on a movie display area different from the still image display area of the two-sided copy setting screen image, an image representing contents of the selected process in a prescribed state.

Abstract: Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein Q is a bond or —N(R5)—; T is a bond, —O—, —C(O)—; S, —N(R5)—, or —C(R6?R7?); U is a bond or —C(R6)(R7)— Y is C or N; Z is C or N; ring A, including variables Y and Z, is a three to nine membered cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, aryl, and heteroaryl ring having 0 to 4, preferably 0 to 2, heteroatoms independently selected from the group consisting of O, S, N and —N(R)—, wherein ring A is unsubstituted or substituted with 1 to 5 independently selected R1 moieties and/or oxo when ring A is cycloalkyl, cycloalkenyl, heterocyclyl or heterocyclenyl; and R, R1, R2, R3, R4, R5, R6, R6, R7 and R7? are as defined in the specification; pharmaceutical compositions comprising the compounds of formula I and the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases.

Abstract: To improve a workability in assembling and disassembling of parts of a lighting device. A backlight unit 12 includes an LED board 18 having LEDs 17, a chassis 14, a light guide member 19 having an end portion arranged to face the LEDs 17, a power supply board 21 arranged outside the chassis 14 and supplying drive power to the LEDs 17, and a connector 20 mounted to the chassis 14 and supplying power between the power supply board 21 and the LEDs 17. The connector 20 includes an LED board supporting portion 20a that supports the LED board 18, a power supply board supporting portion 20b having a plate surface along which the power supply board 21 is inserted into and removed from and that supports the inserted power supply board 21, and a connection terminal 28 that comes in contact with the power supply board 21 with allowing relative slide in an inserting and removing direction of the power supply board 21.

Abstract: The present invention relates to Pyriraidine Derivatives of formula (I), compositions comprising a Pyrimidine Derivative, and methods of using the Pyrimidine Derivatives for treating or preventing obesity, diabetes, a diabetic complication, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of a G protein-coupled receptor (GPCR) in a patient.

Abstract: A display which includes an array of pixels. Each pixel includes a hydrophobic layer; an electro-wetting fluid adjacent the hydrophobic layer, the electro-wetting fluid including at least first and second fluids immiscible with each other and having different polar properties and different optical properties; and at least one electrode wherein application of a voltage to the electrode alters a wetting effect of the electro-wetting fluid on the hydrophobic layer in a light-modulating area of the pixel. The display further includes a light-concentrating substrate including an array of light-concentrating structures each configured to concentrate light onto the light-modulating area of a corresponding one or more pixels within the array of pixels.

Abstract: A TFT 17 provided on a substrate 3 is provided. The TFT 17 includes a gate electrode 31, a gate insulating film 32, a semiconductor 33, a source electrode 34, a drain electrode 35, and a protection film 36. The semiconductor 33 includes a metal oxide semiconductor. The semiconductor 33 has a source portion 33a which is in contact with the source electrode 34, a drain portion 33b which is in contact with the drain electrode 35, and a channel portion 33c which is exposed through the source electrode 34 and the drain electrode 35. A conductive layer 37 having a relatively small electrical resistance is formed in each of the source portion 33a and the drain portion 33b. The conductive layer 37 is removed from the channel portion 33c.

Abstract: It is expected to provide an image display apparatus and image display method that can reduce the risk that an image quality is undermined due to a halo phenomenon caused by the leak of light passing through a non-corresponding color filter from a LED. The image display apparatus can respectively control luminous efficiencies of plural color LEDs, i.e., R-LED (11a), G-LED (11b) and B-LED (11c) that emit light through a color filter to a displaying unit. The image display apparatus obtains luminous efficiencies for a frame of RGB image signal (S2), calculates a light leak amount and then detects whether the halo phenomenon may occur or not (S3-S5). When the halo phenomenon is considered to occur, the luminous efficiencies of LEDs (11a, 11b, 11c) included in the liquid crystal display apparatus are controlled to make the light from the LEDs (11a, 11b, 11c) become close to white light (S8).

Abstract: A signal distribution circuit (3) includes (i) a redundancy TFT element (8) provided so as to have a channel width identical to those of driving TFT elements (7), (ii) first redundancy lines (9a, 9b), (iii) a second redundancy line (10), and (iv) a third redundancy line (11). It is therefore possible to provide a liquid crystal display device including the signal distribution circuit (3) in which, even in a case where a leaking part (a defect part) is generated in any of the driving TFT elements (7), it does not take long to restore the leaking part, and productivity can be improved, the driving TFT elements (7) keeping respective channel widths identical to one another even after the leaking part is restored.

Abstract: The subject invention provides an X-ray visible drug delivery device for subdermal administration of a contraceptive or hormone replacement therapy.

Abstract: Provided is a touch sensor-equipped display device that is not susceptible to the effect of noise caused by the reversal of polarity of the common voltage of the display device, without using special circuits. The touch sensor-equipped display device includes: a touch sensor unit 7 having a plurality of sensor electrodes; a sensor output read circuit 21 that is sequentially connected to the respective sensor electrodes and that outputs a signal voltage corresponding to the electrical characteristics of the sensor electrode connected thereto; a sensor control circuit 23 that supplies a control signal to the sensor output read circuit 21; and a coordinate calculation circuit 22 that detects a contact position on the basis of the signal voltage.

Abstract: One embodiment of a semiconductor device according to the present invention includes a substrate, a base compound semiconductor layer layered on the substrate to form a base, a channel defining compound semiconductor layer layered on the base compound semiconductor layer to define a channel, and an impact ionization control layer that is layered within a layering range of the base compound semiconductor layer and controls the location of impact ionization, wherein the base compound semiconductor layer is formed of a first compound semiconductor, the channel defining compound semiconductor layer is formed of a second compound semiconductor, and the impact ionization control layer is formed of a third compound semiconductor that has a smaller band gap than the first compound semiconductor.

Abstract: An LED drive circuit (10) for driving an LED circuit (220) includes: a constant current driver (110) including transistors (111-114) whose collector terminals are respectively connected with LED rows (221-224) connected with each other in parallel and whose emitter terminals are grounded; and an LED drive control section (120) for setting a voltage to be commonly applied on the LED rows (221-224), the setting being performed in accordance with a maximum base current out of base currents of the transistors (111-114).

Abstract: In one embodiment of the present invention, when a still image is displayed, applied voltages respectively corresponding to a total of n (n being an integer of not less than 4) types of gradation 0 to (n?1) are outputted to pixels. When a moving image is displayed, an applied voltage corresponding to a predetermined gradation m (1?m?(n?2)) is applied to the pixels instead of applied voltages respectively corresponding to gradations of less than the predetermined gradation m. Overdrive driving is performed with respect to a total of n types of gradation.

Abstract: The image forming apparatus of the present invention includes an image forming main device which has a control section. The control section (a) obtains, from an external device via a communication device, option information indicative of an at least one optional device and eco-information indicative of an amount of greenhouse-gas emitted due to the at least one optional device, (b) controls a display device to display the option information and the eco-information, and (c) sends, to the external device via the communication device, an order for an optional device selected by a user via the input device out of the at least one optional device indicated by the option information displayed on the display device.

Abstract: The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a pharmaceutically acceptable salt thereof, or a mixture thereof, according to a continuous schedule having a dosage interval of once weekly, biweekly, twice monthly or once monthly.

Abstract: Embodiments of the present invention comprise systems and methods for processing of data related to video wherein reduced bit depth intermediate calculations are enabled.